Published in Oncogene on October 27, 2005
The hairless mouse in skin research. J Dermatol Sci (2008) 1.95
Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem Photobiol (2010) 0.87
P53 mutation is a rare event in Merkel cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol (2011) 0.86
Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesis. Am J Pathol (2010) 0.84
Oxidative stress and skin cancer: an overview. Indian J Clin Biochem (2012) 0.80
The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes. Cytokine (2013) 0.80
Role of p53 and CDKN2A inactivation in human squamous cell carcinomas. J Biomed Biotechnol (2007) 0.80
MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma. Mol Cancer Res (2014) 0.78
Tumor-promoting role of TGFβ1 signaling in ultraviolet B-induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells. Carcinogenesis (2013) 0.78
Establishment and characterization of an osteopontin-null cutaneous squamous cell carcinoma cell line. In Vitro Cell Dev Biol Anim (2010) 0.78
Slug expression in mouse skin and skin tumors is not regulated by p53. J Invest Dermatol (2013) 0.75
Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis. Carcinogenesis (2016) 0.75
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol (2009) 2.26
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer (2009) 2.26
Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol (2004) 2.17
Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol (2010) 2.09
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012. Eur J Cancer (2012) 2.05
[The Nessos shirt: did Herakles die from scleroderma?]. J Dtsch Dermatol Ges (2011) 2.03
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study. J Am Acad Dermatol (2012) 2.01
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs (2014) 1.99
The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.99
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol (2003) 1.95
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J Clin Oncol (2004) 1.84
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol (2008) 1.78
Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology (2004) 1.74
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J Clin Invest (2010) 1.73
MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol (2008) 1.72
Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat (2007) 1.72
The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS One (2011) 1.71
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (2008) 1.70
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Cellular and molecular events leading to the development of skin cancer. Mutat Res (2005) 1.69
T1799A BRAF mutation is common in PUVA lentigines. J Invest Dermatol (2006) 1.59
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy. Arch Dermatol (2006) 1.58
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol (2003) 1.54
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene. J Invest Dermatol (2004) 1.48
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med (2009) 1.45
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci U S A (2011) 1.42
Jumping into the future using teledermoscopy. Skinmed (2003) 1.41
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer (2006) 1.38
The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol (2005) 1.36
An Italian study on psoriasis and depression. Dermatology (2006) 1.31
Eccrine poroma in an unusual site: a clinical and dermoscopic simulator of amelanotic melanoma. J Am Acad Dermatol (2005) 1.28
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. J Am Acad Dermatol (2007) 1.28
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res (2008) 1.27
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am J Pathol (2006) 1.24
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med (2015) 1.20
A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet (2013) 1.17
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res (2004) 1.15
Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev Mol Med (2002) 1.14
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res (2003) 1.13
p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol (2006) 1.13
Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol (2012) 1.12
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc Natl Acad Sci U S A (2008) 1.12
The spectrum of dermatoscopic patterns in blue nevi. J Am Acad Dermatol (2011) 1.11
Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. Proteomics (2006) 1.11
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer (2010) 1.10
Dermoscopic changes in acral melanocytic nevi during digital follow-up. Arch Dermatol (2007) 1.10
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias. J Invest Dermatol (2008) 1.10
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08
Treatment of occupational koilonychia with tazarotene gel. Acta Derm Venereol (2003) 1.07
Phrynoderma: a cutaneous sign of an inadequate diet. CMAJ (2007) 1.06
P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol (2008) 1.06
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res (2006) 1.05
Giant pilomatricoma. Am J Dermatopathol (2007) 1.05
CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol (2004) 1.04
Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an interdisciplinary study on 107 cases. Cancer (2002) 1.04
Impact of dermoscopy on the clinical management of pigmented skin lesions. Clin Dermatol (2002) 1.02
Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene (2004) 0.99
Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol (2006) 0.98
p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol (2008) 0.98
Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. J Invest Dermatol (2002) 0.98
Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase. Oncogene (2003) 0.98
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg (2005) 0.96
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia. J Immunol (2011) 0.95
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. Eur J Cancer (2012) 0.95
Molecular mechanisms of photocarcinogenesis. Front Biosci (2002) 0.95
Apremilast for the treatment of psoriasis. Expert Opin Pharmacother (2015) 0.94
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Dermatol Ther (2011) 0.94
Kaposi's sarcoma of the glans penis in an immunocompetent patient. Eur J Dermatol (2004) 0.93
High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther (2006) 0.93
Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst (2006) 0.92
Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score. Am J Clin Dermatol (2010) 0.92
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered (2006) 0.91
Erysipeloid cutaneous metastasis from bladder carcinoma. Eur J Dermatol (2007) 0.91
Pyruvic acid peels for the treatment of photoaging. Dermatol Surg (2004) 0.91
Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma. Dermatol Surg (2002) 0.91
Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma. Eur J Dermatol (2008) 0.90
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases. Case Rep Dermatol (2013) 0.90
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J Invest Dermatol (2004) 0.90
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene. J Invest Dermatol (2004) 0.90
Models and mechanisms in malignant melanoma. Mol Carcinog (2007) 0.90
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol (2002) 0.90
Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study. Dermatology (2012) 0.90
The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol (2006) 0.89
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol (2006) 0.89
Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol (2009) 0.89
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. Am J Ophthalmol (2006) 0.89